HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ke-Neng Chen Selected Research

homeobox protein HOXA9

2/2005Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ke-Neng Chen Research Topics

Disease

18Neoplasms (Cancer)
11/2021 - 12/2002
16Esophageal Squamous Cell Carcinoma
02/2024 - 02/2005
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2023 - 01/2017
5Esophageal Neoplasms (Esophageal Cancer)
10/2022 - 05/2014
5Lung Neoplasms (Lung Cancer)
01/2022 - 01/2017
4Thymoma (Thymic Carcinoma)
07/2016 - 07/2016
3Neoplasm Metastasis (Metastasis)
11/2021 - 08/2016
3Thymus Neoplasms (Thymus Neoplasm)
07/2016 - 07/2016
2Myasthenia Gravis
07/2016 - 07/2016
1Pathologic Complete Response
01/2024
1Chylothorax
05/2023
1Disease Progression
01/2022
1Acute Lung Injury
01/2022
1Plasmacytoma
11/2021
1Lymphatic Metastasis
03/2020
1Melanoma (Melanoma, Malignant)
03/2020
1Pulmonary Atelectasis
01/2019
1Neutropenia
01/2018
1Vomiting
01/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2018
1Carcinogenesis
05/2014
1Esophageal Diseases
05/2014
1Infections
07/2005
1Carcinoma (Carcinomatosis)
12/2002
1Breast Neoplasms (Breast Cancer)
12/2002

Drug/Important Bio-Agent (IBA)

6Cisplatin (Platino)FDA LinkGeneric
01/2023 - 01/2018
5Gefitinib (Iressa)FDA Link
11/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2016
3Vinorelbine (Navelbine)FDA LinkGeneric
01/2021 - 01/2018
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2019
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2023 - 01/2019
2GemcitabineFDA Link
01/2023 - 01/2019
1Immune Checkpoint InhibitorsIBA
08/2023
1pembrolizumabIBA
08/2023
1NivolumabIBA
01/2022
1Complement System Proteins (Complement)IBA
12/2020
1phosphatidyl-N-monomethylaminoethanolIBA
03/2020
1PlatinumIBA
11/2019
1Cullin Proteins (Cullins)IBA
01/2019
1Kelch-Like ECH-Associated Protein 1IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1Paclitaxel (Taxol)FDA LinkGeneric
01/2019
1berzosertibIBA
01/2018
1histone H3 trimethyl Lys4IBA
01/2018
1Cadherins (E-Cadherin)IBA
02/2017
1Circulating Tumor DNAIBA
01/2017
1Annexin A2 (Annexin II)IBA
05/2014
1superoxide dismutase 2IBA
05/2014
1EndopeptidasesIBA
08/2005
1ZincIBA
08/2005
1Matrix Metalloproteinases (MMPs)IBA
08/2005
1Digoxin (Digitek)FDA LinkGeneric
07/2005
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
02/2005
1homeobox protein HOXA9IBA
02/2005
1Codon (Codons)IBA
12/2002

Therapy/Procedure

14Drug Therapy (Chemotherapy)
01/2023 - 12/2015
11Therapeutics
11/2021 - 07/2016
8Neoadjuvant Therapy
02/2024 - 01/2016
5Esophagectomy
05/2023 - 05/2014
4Adjuvant Chemotherapy
01/2022 - 01/2018
3Immunotherapy
09/2022 - 06/2018
3Radiotherapy
03/2022 - 07/2016
2Thymectomy
07/2016 - 07/2016
1Ligation
05/2023
1Adjuvant Radiotherapy
11/2021
1Lymph Node Excision (Lymph Node Dissection)
07/2020
1One-Lung Ventilation
01/2019
1Induction Chemotherapy
01/2019
1Precision Medicine
01/2017
1Radiofrequency Ablation
08/2016